Showing results (11-20 of 34) with videos related to
Sort By:
Pageof 4
Investigative and Clinical Urology|July 16, 2020
A novel urinary mRNA signature using the droplet digital polymerase chain reaction platform improves discrimination between prostate cancer and benign prostatic hyperplasia within the prostate-specific antigen gray zoneHo Won Kang, Hee Youn Lee, Young Joon Byun, et al.Journal of Korean Medical Science|November 20, 2018
CDC6 mRNA Expression Is Associated with the Aggressiveness of Prostate CancerYe-Hwan Kim, Young Joon Byun, Won Tae Kim, et al.Investigative and Clinical Urology|January 10, 2024
COL6A1 expression as a potential prognostic biomarker for risk stratification of T1 high grade bladder cancer: Unveiling the aggressive nature of a distinct non-muscle invasive subtypeKyeong Kim, Young Joon Byun, Chuang-Ming Zheng, et al.International Journal of Molecular Sciences|December 10, 2021
Prognostic Value of BUB1 for Predicting Non-Muscle-Invasive Bladder Cancer ProgressionXuan-Mei Piao, Chaelin You, Young Joon Byun, et al.International Journal of Molecular Sciences|October 26, 2024
Differential Urinary Microbiome and Its Metabolic Footprint in Bladder Cancer Patients Following BCG TreatmentKyungchan Min, Chuang-Ming Zheng, Sujeong Kim, et al.International Journal of Molecular Sciences|November 26, 2022
Utility of a Molecular Signature for Predicting Recurrence and Progression in Non-Muscle-Invasive Bladder Cancer Patients: Comparison with the EORTC, CUETO and 2021 EAU Risk GroupsXuan-Mei Piao, Seon-Kyu Kim, Young Joon Byun, et al.Urologic Oncology|November 18, 2018
Diagnostic value of combined IQGAP3/BMP4 and IQGAP3/FAM107A expression ratios in urinary cell-free DNA for discriminating bladder cancer from hematuriaYanjie Xu, Ye-Hwan Kim, Pildu Jeong, et al.Investigative and Clinical Urology|March 4, 2022
Urinary hsv2-miR-H9 to hsa-miR-3659 ratio is an effective marker for discriminating prostate cancer from benign prostate hyperplasia in patients within the prostate-specific antigen grey zoneHo Won Kang, Young Joon Byun, Sung Min Moon, et al.Cancer Genetics|November 11, 2022
Study on the use of Nanostring nCounter to analyze RNA extracted from formalin-fixed-paraffin-embedded and fresh frozen bladder cancer tissuesChuang-Ming Zheng, Xuan-Mei Piao, Young Joon Byun, et al.Urologic Oncology|December 19, 2020
A prognostic immune predictor, HLA-DRA, plays diverse roles in non-muscle invasive and muscle invasive bladder cancerXuan-Mei Piao, Ho Won Kang, Pildu Jeong, et al.Pageof 4